Empagliflozin

Dr. McPhee: This is not quite the best option in this case. Empagliflozin can an excellent drug, particularly for patients with certain co-morbidities, such as heart failure, chronic kidney disease, and established or high atherosclerotic cardiovascular (ASCVD) risk. It can also help when weight loss is a goal. There is no compelling cardiorenal indication to start it ahead of another drug that is more cost-effective and could also provide benefits in preventing complications and reducing weight.

Please go back and reconsider.

  • What should Anna do? [undo]
  • Root Node [undo]
  • Bisoprolol (Beta-blocker) [undo]
  • Glycerol trinitrate (organic nitrate) [undo]
  • Dobutamine (beta agonist) [undo]
  • 8 y.o. Child came in the ER with his mother [undo]
  • Virtual Patient Scenario: Maria's Telemonitoring Empowerment Journey [undo]
  • Bring the patient to Primary Health Care [undo]
  • Alotetaan! [undo]
  • Ο σύλλογος της περιοχής σου θέλει να βοηθήσει τους γιατρούς που φροντίζουν τους ασθενείς με κορονοϊό. [undo]
  • Ei syödä [undo]
  • Root Node [undo]
  • Adverse effect to budesonide [undo]
  • A 70 years old male with hematuria [undo]
  • Πρωτεϊνοσύνθεση [undo]
  • Physical Examination and Lab Tests [undo]
  • Empagliflozin [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21112
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway